Silverberg Bernstein Capital Management LLC Volitionrx LTD Transaction History
Silverberg Bernstein Capital Management LLC
- $109 Billion
- Q3 2024
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 142,618 shares of VNRX stock, worth $89,849. This represents 0.08% of its overall portfolio holdings.
Number of Shares
142,618
Previous 144,618
1.38%
Holding current value
$89,849
Previous $87.5 Million
2.04%
% of portfolio
0.08%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
26Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$5.67 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$3.84 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA730KShares$460,1820.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$401,1000.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$325,1250.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...